Our History

We Strive Toward Greater Heights


 History


We strive towards greater heights. 

2025
  • 01  IND-enabling studies for DRT-101 began at BiotoxTech in South Korea.
  • 02 OSRH launched on NASDAQ as a result of the business combination of OSR Holdings Co., Ltd and BLAC.

2024
  • 06  OSR Holdings Co., Ltd and BLAC (a NASDAQ SPAC) filed S-4 for business combination

2023
  • 02  Acquired by OSR Holdings Co., Ltd. 

2021
  • 06  National patent filings for DRT-101 

2019
  • 11  PCT Patent application for DRT-101 

2016
  • 04  Clinical Trial Initiation for AB204-Patented ‘Spinal Fusion Therapy

2015
  • 07  Acquisition of Medical Device Compliance Certification (GMP Approval) for Pharmaceutical/Medical Device
          Division Facilities
  • 07  Approval of the Investigational New Drug (IND) Application for AB204-Patented Spinal Fusion Therapy

2013
  •  05  Expansion of protein drug raw material production plant and construction of new production facilities
  •  04  Completion of protein drug production facilities with 50L and 70L capacities 
  •  04  Agreement signed with Dong-A Socio Holdings for production of AB204 protein drug raw material 

2012
  • 07  Founding of Biobetter Biologics at Incheon Technopark


 Certifications
Various Certifications and Trademarks 
Certificate


Various Certifications and Trademarks

Company Info



  • E-MAIL  ir@osr-holdings.com
  • Address  Building B 302, 30 Songdomirae-ro, Yeonsu-gu,  Incheon, Republic of Korea

Privacy Policy  I  Terms of Service
Copyright โ“’ Darnatein All rights reserved.